Development Finance Corp. and Biological E. Limited Finalize Financing Arrangement to Expand COVID-19 Vaccine Manufacturing Capabilities in India
October 26, 2021
October 26, 2021
HYDERABAD, India, Oct. 26 -- The U.S. International Development Finance Corp. issued the following news release:
U.S. International Development Finance Corporation (DFC) COO David Marchick and Biological E. Limited Managing Director Mahima Datla today unveiled the expansion of Biological E.'s vaccine manufacturing facility in Hyderabad and finalized a U.S. government financing arrangement formalizing $50 million to expand the company's capacity to produce COVID-19 vaccines. The cont . . .
U.S. International Development Finance Corporation (DFC) COO David Marchick and Biological E. Limited Managing Director Mahima Datla today unveiled the expansion of Biological E.'s vaccine manufacturing facility in Hyderabad and finalized a U.S. government financing arrangement formalizing $50 million to expand the company's capacity to produce COVID-19 vaccines. The cont . . .